ID   BPNT1_RAT               Reviewed;         308 AA.
AC   Q9Z1N4;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   22-JUL-2015, entry version 109.
DE   RecName: Full=3'(2'),5'-bisphosphate nucleotidase 1;
DE            EC=3.1.3.7;
DE   AltName: Full=Bisphosphate 3'-nucleotidase 1;
DE   AltName: Full=PAP-inositol 1,4-phosphatase;
DE            Short=PIP;
DE   AltName: Full=scHAL2 analogous 3;
GN   Name=Bpnt1; Synonyms=Sal3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=10347153; DOI=10.1074/jbc.274.23.16034;
RA   Lopez-Coronado J.M., Belles J.M., Lesage F., Serrano R.,
RA   Rodriguez P.L.;
RT   "A novel mammalian lithium-sensitive enzyme with a dual enzymatic
RT   activity, 3'-phosphoadenosine 5'-phosphate phosphatase and inositol-
RT   polyphosphate 1-phosphatase.";
RL   J. Biol. Chem. 274:16034-16039(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 28-40; 145-167; 202-217; 225-232; 262-274 AND
RP   278-297, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [4]
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RA   Lubec G., Chen W.-Q.;
RL   Submitted (FEB-2007) to UniProtKB.
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.69 ANGSTROMS) OF 5-308 IN COMPLEX WITH
RP   MAGNESIUM AND AMP.
RX   PubMed=11812139; DOI=10.1006/jmbi.2001.5271;
RA   Patel S., Yenush L., Rodriguez P.L., Serrano R., Blundell T.L.;
RT   "Crystal structure of an enzyme displaying both inositol-
RT   polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate
RT   phosphatase activities: a novel target of lithium therapy.";
RL   J. Mol. Biol. 315:677-685(2002).
CC   -!- FUNCTION: Converts adenosine 3'-phosphate 5'-phosphosulfate (PAPS)
CC       to adenosine 5'-phosphosulfate (APS) and 3'(2')-phosphoadenosine
CC       5'- phosphate (PAP) to AMP. Has 1000-fold lower activity towards
CC       inositol 1,4-bisphosphate (Ins(1,4)P2) and inositol 1,3,4-
CC       trisphosphate (Ins(1,3,4)P3), but does not hydrolyze Ins(1)P,
CC       Ins(3,4)P2, Ins(1,3,4,5)P4 or InsP6.
CC       {ECO:0000269|PubMed:10347153}.
CC   -!- CATALYTIC ACTIVITY: Adenosine 3',5'-bisphosphate + H(2)O =
CC       adenosine 5'-phosphate + phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Uncompetitive inhibition by micromolar
CC       concentrations of lithium. Competitive inhibition by inositol 1,4-
CC       bisphosphate. Inhibited by calcium ions.
CC       {ECO:0000269|PubMed:10347153}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, brain, spleen,
CC       lung, liver, skeletal muscle, kidney and testis.
CC       {ECO:0000269|PubMed:10347153}.
CC   -!- SIMILARITY: Belongs to the inositol monophosphatase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ000347; CAA04022.1; -; mRNA.
DR   EMBL; BC085692; AAH85692.1; -; mRNA.
DR   RefSeq; NP_741987.1; NM_171990.2.
DR   RefSeq; XP_006250493.1; XM_006250431.2.
DR   UniGene; Rn.8453; -.
DR   PDB; 1JP4; X-ray; 1.69 A; A=1-308.
DR   PDBsum; 1JP4; -.
DR   ProteinModelPortal; Q9Z1N4; -.
DR   SMR; Q9Z1N4; 5-308.
DR   STRING; 10116.ENSRNOP00000003249; -.
DR   PhosphoSite; Q9Z1N4; -.
DR   PaxDb; Q9Z1N4; -.
DR   PRIDE; Q9Z1N4; -.
DR   Ensembl; ENSRNOT00000003249; ENSRNOP00000003249; ENSRNOG00000002378.
DR   GeneID; 64473; -.
DR   KEGG; rno:64473; -.
DR   UCSC; RGD:621833; rat.
DR   CTD; 10380; -.
DR   RGD; 621833; Bpnt1.
DR   eggNOG; NOG150078; -.
DR   GeneTree; ENSGT00530000063462; -.
DR   HOGENOM; HOG000293205; -.
DR   HOVERGEN; HBG050719; -.
DR   InParanoid; Q9Z1N4; -.
DR   KO; K01082; -.
DR   OMA; INQPFYN; -.
DR   OrthoDB; EOG7WQ7SQ; -.
DR   PhylomeDB; Q9Z1N4; -.
DR   BRENDA; 3.1.3.57; 5301.
DR   Reactome; REACT_341577; Cytosolic sulfonation of small molecules.
DR   SABIO-RK; Q9Z1N4; -.
DR   EvolutionaryTrace; Q9Z1N4; -.
DR   NextBio; 613262; -.
DR   PRO; PR:Q9Z1N4; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Genevisible; Q9Z1N4; RN.
DR   GO; GO:0008441; F:3'(2'),5'-bisphosphate nucleotidase activity; IDA:RGD.
DR   GO; GO:0004441; F:inositol-1,4-bisphosphate 1-phosphatase activity; IDA:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:RGD.
DR   GO; GO:0016311; P:dephosphorylation; IDA:GOC.
DR   GO; GO:0046854; P:phosphatidylinositol phosphorylation; IEA:InterPro.
DR   InterPro; IPR020583; Inositol_monoP_metal-BS.
DR   InterPro; IPR000760; Inositol_monophosphatase.
DR   InterPro; IPR020550; Inositol_monophosphatase_CS.
DR   PANTHER; PTHR20854; PTHR20854; 1.
DR   Pfam; PF00459; Inositol_P; 1.
DR   PRINTS; PR00377; IMPHPHTASES.
DR   PROSITE; PS00629; IMP_1; 1.
DR   PROSITE; PS00630; IMP_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Hydrolase; Lithium; Magnesium;
KW   Metal-binding; Phosphoprotein; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.4}.
FT   CHAIN         2    308       3'(2'),5'-bisphosphate nucleotidase 1.
FT                                /FTId=PRO_0000142529.
FT   REGION      119    122       Substrate binding.
FT   REGION      195    198       Substrate binding.
FT   REGION      220    224       Substrate.
FT   METAL        74     74       Magnesium 1.
FT                                {ECO:0000269|PubMed:11812139}.
FT   METAL       117    117       Magnesium 1.
FT                                {ECO:0000269|PubMed:11812139}.
FT   METAL       117    117       Magnesium 2.
FT                                {ECO:0000269|PubMed:11812139}.
FT   METAL       119    119       Magnesium 1; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:11812139}.
FT   METAL       120    120       Magnesium 2.
FT                                {ECO:0000269|PubMed:11812139}.
FT   METAL       247    247       Magnesium 2.
FT                                {ECO:0000269|PubMed:11812139}.
FT   BINDING      74     74       Substrate. {ECO:0000250}.
FT   BINDING     242    242       Substrate; via carbonyl oxygen.
FT   BINDING     247    247       Substrate.
FT   MOD_RES       2      2       N-acetylalanine. {ECO:0000269|Ref.4}.
FT   MOD_RES     122    122       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O95861}.
FT   MOD_RES     244    244       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9Z0S1}.
FT   HELIX         7     32       {ECO:0000244|PDB:1JP4}.
FT   STRAND       38     42       {ECO:0000244|PDB:1JP4}.
FT   STRAND       45     47       {ECO:0000244|PDB:1JP4}.
FT   HELIX        49     65       {ECO:0000244|PDB:1JP4}.
FT   STRAND       69     75       {ECO:0000244|PDB:1JP4}.
FT   HELIX        84     86       {ECO:0000244|PDB:1JP4}.
FT   HELIX        93     96       {ECO:0000244|PDB:1JP4}.
FT   HELIX       102    104       {ECO:0000244|PDB:1JP4}.
FT   HELIX       109    111       {ECO:0000244|PDB:1JP4}.
FT   STRAND      112    120       {ECO:0000244|PDB:1JP4}.
FT   HELIX       122    126       {ECO:0000244|PDB:1JP4}.
FT   HELIX       130    132       {ECO:0000244|PDB:1JP4}.
FT   STRAND      134    141       {ECO:0000244|PDB:1JP4}.
FT   STRAND      144    152       {ECO:0000244|PDB:1JP4}.
FT   TURN        153    158       {ECO:0000244|PDB:1JP4}.
FT   STRAND      167    172       {ECO:0000244|PDB:1JP4}.
FT   TURN        173    175       {ECO:0000244|PDB:1JP4}.
FT   STRAND      176    180       {ECO:0000244|PDB:1JP4}.
FT   STRAND      191    198       {ECO:0000244|PDB:1JP4}.
FT   HELIX       201    208       {ECO:0000244|PDB:1JP4}.
FT   STRAND      213    219       {ECO:0000244|PDB:1JP4}.
FT   HELIX       221    229       {ECO:0000244|PDB:1JP4}.
FT   STRAND      234    238       {ECO:0000244|PDB:1JP4}.
FT   HELIX       245    257       {ECO:0000244|PDB:1JP4}.
FT   STRAND      261    263       {ECO:0000244|PDB:1JP4}.
FT   STRAND      284    289       {ECO:0000244|PDB:1JP4}.
FT   HELIX       291    297       {ECO:0000244|PDB:1JP4}.
FT   HELIX       300    305       {ECO:0000244|PDB:1JP4}.
SQ   SEQUENCE   308 AA;  33174 MW;  478C375057E88EC9 CRC64;
     MASSHNVLMR LVASAYSIAQ KAGTIVRCVI AEGDLGIVQK TSATDLQTKA DRMVQMSICS
     SLSRKFPKLT IIGEEDLPPG EVDQELIEDG QSEEILKQPC PSQYSAIKEE DLVVWVDPVD
     GTKEYTEGLL DNVTVLIGIA YEGKAIAGII NQPYYNYQAG PDAVLGRTIW GVLGLGAFGF
     QLKEAPAGKH IITTTRSHSN KLVTDCIAAM NPDNVLRVGG AGNKIIQLIE GKASAYVFAS
     PGCKKWDTCA PEVILHAVGG KLTDIHGNPL QYDKEVKHMN SAGVLAALRN YEYYASRVPE
     SVKSALIP
//
